0001181431-13-055307.txt : 20131028
0001181431-13-055307.hdr.sgml : 20131028
20131028165518
ACCESSION NUMBER: 0001181431-13-055307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131023
FILED AS OF DATE: 20131028
DATE AS OF CHANGE: 20131028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Cheryl
CENTRAL INDEX KEY: 0001529371
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 131173628
MAIL ADDRESS:
STREET 1: C/O MEDIVATION, INC.
STREET 2: 201 SPEAR ST., 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
4
1
rrd393446.xml
COHEN - SAME DALE SALE (10/23/2013)
X0306
4
2013-10-23
0
0001011835
MEDIVATION, INC.
MDVN
0001529371
Cohen Cheryl
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
0
1
0
0
Chief Commercial Officer
Common Stock
2013-10-23
4
M
0
25000
9.605
A
50439
D
Common Stock
2013-10-23
4
S
0
25000
63.0498
D
25439
D
Common Stock
2013-10-24
4
M
0
25000
9.605
A
50439
D
Common Stock
2013-10-24
4
S
0
23000
65.4047
D
27439
D
Common Stock
2013-10-24
4
S
0
2000
66.019
D
25439
D
Stock Option (Right to Buy)
9.605
2013-10-23
4
D
0
25000
0.00
D
2021-09-15
Common Stock
25000
350000
D
Stock Option (Right to Buy)
9.605
2013-10-24
4
D
0
25000
0.00
D
2021-09-15
Common Stock
25000
325000
D
The shares were sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $63.03 to $63.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on September 15, 2012, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest of the first day of each full month thereafter.
The shares were sold at prices ranging from $65.00 to $65.87. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Patrick Machado, Attorney-in-fact
2013-10-28